> Indian API-maker Orchid Chemicals & Pharmaceuticals reported dismal results in its last quarter, in part because a plant in India was closed after pollution concerns. Story
> Johnson & Johnson ($JNJ), which has restricted Doxil treatment to current cancer patients because of manufacturing problems at the Ben Venue Laboratories plant where it was made, now has a limited supply that will be made available for up to 2,000 new patients. News
> Contract manufacturer Angel Biotechnology Holdings ($ABH) has paid £200,000 ($320,470) for a 6,500-square-foot biomaterial and collagen manufacturing plant in Glasgow, U.K., to make purified GMP medical-grade collagen. Release
> With a new plant in China, Danish biotech group Novozymes is now producing hyaluronic acid for pharmaceutical manufacturers. More
> The International Conference on Harmonisation (ICH) has sent its Q11 guidelines on API manufacturing to regulators in the U.S., EU and Japan in an effort to standardize applications. Item
> API-maker Flamma Italy has bought a plant near Milan that will allow it to handle industrial production of triphosgene and ammonia gas. Article